leadf
logo-loader
viewBioHarvest Sciences Inc.
(
CSE:BHSCOTC:CNVCF
)

BioHarvest Sciences able to achieve major milestone as company scales up cannabis cells

BioHarvest Sciences CEO Ilan Sobel joined Steve Darling from with Proactive to share news the company has been able to successfully scaled its Cannabis cells with trichomes production by a factor of 250x and it is now growing Cannabis in medium-scale bioreactors.

Sobel telling Proactive this now means that BioHarvest will now move on to the next scale-up milestone, industrial-scale production. That along with drying will be the completion of the Company’s Cannabis development program and they will be ready to bring to market.

Quick facts: BioHarvest Sciences Inc.

Follow
CSE:BHSC

Price: 0.34 CAD

Market Cap: $146.71 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

BioHarvest's cannabis vertical takes major step forward with Trichome Structure

BioHarvest Sciences CEO Ilan Sobel joined Steve Darling from Proactive to share news the company has, unveiled what they are calling a new, groundbreaking “Amalgamated Trichomes Coral Structure” Sobel explains what that is and why he this has the potential to revolutionize the production of...

on 08/19/2021

2 min read